Charles Conway
2017
In 2017, Charles Conway earned a total compensation of $1.6M as Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd..
Compensation breakdown
| Bonus | $191,900 |
|---|---|
| Option Awards | $1,118,433 |
| Salary | $305,883 |
| Other | $9,932 |
| Total | $1,626,148 |
Conway received $1.1M in option awards, accounting for 69% of the total pay in 2017.
Conway also received $191.9K in bonus, $305.9K in salary and $9.9K in other compensation.
Rankings
In 2017, Charles Conway's compensation ranked 6,569th out of 14,666 executives tracked by ExecPay. In other words, Conway earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,569 out of 14,666 | 55th |
Division Manufacturing | 2,428 out of 5,770 | 58th |
Major group Chemicals And Allied Products | 779 out of 2,074 | 62nd |
Industry group Drugs | 601 out of 1,730 | 65th |
Industry Pharmaceutical Preparations | 475 out of 1,329 | 64th |
Source: SEC filing on March 29, 2018.
Conway's colleagues
We found two more compensation records of executives who worked with Charles Conway at Biohaven Pharmaceutical Holding Co Ltd. in 2017.